The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInvestment Co. Regulatory News (INV)

Share Price Information for Investment Co. (INV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 319.00
Bid: 310.00
Ask: 328.00
Change: 0.00 (0.00%)
Spread: 18.00 (5.806%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 319.00
INV Live PriceLast checked at -
Investment Company is an Investment Trust

To provide shareholders with an attractive level of dividends coupled with capital growth over the long-term, through the investment in a portfolio of equities, preference shares, loan stocks, debentures and convertibles.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

9 Jul 2018 07:00

RNS Number : 9287T
Investment Company PLC
09 July 2018
 

Monday, 9th July 2018

The Investment Company plc

Board changes

The Investment Company plc ("TIC" or the "Company") announces the following changes to the board with effect from 6th July 2018:

· Sir David Thomson, Peter Allen and Stephen Cockburn retire from the board

· Ian Dighé is appointed Non-Executive Chairman

· Tim Metcalfe is appointed Non-Executive Director

Following these changes, the board consists of Ian Dighé, Martin Perrin and Tim Metcalfe.

The board has made a number of changes to the operations of the Company over recent months including the appointment of a new manager, Fiske plc, and new administrative arrangements. Accordingly, this was viewed as an appropriate moment to refresh the board. The newly constituted board will review the investment strategy of the Company and, should there be any proposed material changes, these will be put forward to shareholders for their approval as required by the Listing Rules of the FCA.

Commenting on the board changes, Ian Dighé said:

"On behalf of shareholders I would like to thank Sir David Thomson, Peter Allen and Stephen Cockburn for their long service to the Company. Together with my new board colleagues, we look forward to working closely with the manager both to drive forward shareholder returns and seeking avenues to grow the size of the Company's assets."

 

For further information please contact:

The Investment Company plc

Ian Dighé 07785 703 261

Martin Perrin 07785 505 337

Fiske plc

Michael Foster 020 7448 4700

Stockdale Securities Limited

Robert Finlay / Rose Ramsden 020 7601 6115

 

 

1. Further details on Ian Dighé

Ian Dighé has significant experience with closed end funds, namely Gartmore Growth Opportunities Trust plc, Artemis Alpha Trust plc and Strategic Equity Capital plc. He was a founder of, and subsequently launched the IPO of, Bridgewell Group plc and he chaired the successful refinancing and growth of Miton Group plc. 

 

Ian Dighé was previously Executive Chairman of Miton Group plc. Miton Group plc had the contract to provide fund management services to the Company from 2013 to 2018. These services were provided by two fund managers employed by Miton Group plc, Gervais Williams and Martin Turner. Ian Dighé resigned as Chairman on 30 November 2017. As a former Executive Chairman of the overall Miton group, one part of which employed the individuals who had responsibility for managing the Company's portfolio, the board do not consider that this compromises his independence as a director of the Company.

 

 At the date of this announcement, Ian has no holding in the ordinary shares of the Company.

 

Ian Dighé was appointed a director of IJ Davies (Tools) Limited in April 1984. In August 1984 the company was put into receivership and wound up. The ultimate position of creditors is unknown. Ian Dighé was also appointed a partner of Matterley Holdings LLP in 2008. In 2009 Matterley Holdings LLP was put into a members' voluntary winding-up and was wound up with no loss to creditors.

 

Ian Dighé was a director of Miton Group plc from 15 February 2011 to 30 November 2017, a director of Strategic Equity Capital plc from 13 November 2009 to 11 November 2015 and a director of Artemis Alpha Trust plc from 10 December 2010 to 1 October 2013.

 

There are no further details required to be disclosed pursuant to Listing Rule 9.6.13R.

 

2. Further details on Tim Metcalfe

 

Tim Metcalfe is an experienced corporate financier, having spent over 20 years working at Robert Fleming & Co., N M Rothschild, Westhouse Securities and Northland Capital Partners and was Joint CEO of Zeus Capital prior to, in 2015, being the co-founder of IFC Advisory, an investor relations and financial PR adviser to small and mid-cap quoted companies.

 

At the date of this announcement, Tim has no holding in the ordinary shares of the Company.

 

 

There are no further details required to be disclosed pursuant to Listing Rule 9.6.13R.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAQQLFBVDFFBBX
Date   Source Headline
29th Apr 20244:56 pmRNSNet Asset Value(s)
22nd Apr 20245:26 pmRNSNet Asset Value(s)
15th Apr 20244:57 pmRNSNet Asset Value(s)
9th Apr 20241:27 pmRNSNet Asset Value(s)
4th Apr 20241:29 pmRNSNet Asset Value(s)
25th Mar 20243:37 pmRNSNet Asset Value(s)
19th Mar 20243:33 pmRNSNet Asset Value(s)
12th Mar 20249:58 amRNSNet Asset Value(s)
5th Mar 20242:56 pmRNSNet Asset Value(s)
28th Feb 20247:00 amRNSHalf-year Report
27th Feb 202412:54 pmRNSNet Asset Value(s)
19th Feb 20244:00 pmRNSNet Asset Value(s)
15th Feb 20244:24 pmRNSDirector Declaration
6th Feb 20241:34 pmRNSNet Asset Value(s)
29th Jan 202410:24 amRNSNet Asset Value(s)
22nd Jan 20245:38 pmRNSNet Asset Value(s)
16th Jan 202410:39 amRNSNet Asset Value(s)
9th Jan 20241:55 pmRNSNet Asset Value(s)
4th Jan 202411:45 amRNSNet Asset Value(s)
27th Dec 20232:08 pmRNSNet Asset Value(s)
18th Dec 20232:11 pmRNSNet Asset Value(s)
12th Dec 20239:32 amRNSNet Asset Value(s)
4th Dec 20231:20 pmRNSNet Asset Value(s)
27th Nov 20233:48 pmRNSNet Asset Value(s)
20th Nov 20233:24 pmRNSNet Asset Value(s)
13th Nov 202310:07 amRNSNet Asset Value(s)
10th Nov 202311:04 amRNSDirector/PDMR Shareholding
9th Nov 202312:07 pmRNSDirector/PDMR Shareholding
7th Nov 202312:03 pmRNSResult of AGM
2nd Nov 20235:04 pmRNSNet Asset Value(s)
31st Oct 20235:06 pmRNSNet Asset Value(s)
23rd Oct 20233:29 pmRNSNet Asset Value(s)
16th Oct 20235:11 pmRNSNet Asset Value(s)
9th Oct 20233:34 pmRNSNet Asset Value(s) - Amendment
9th Oct 20233:19 pmRNSNet Asset Value(s)
6th Oct 202312:02 pmRNSNet Asset Value(s)
4th Oct 20233:22 pmRNSFinal Results
25th Sep 20234:52 pmRNSNet Asset Value(s)
20th Sep 202310:47 amRNSNet Asset Value(s)
11th Sep 20234:40 pmRNSNet Asset Value(s)
9th Aug 20232:04 pmRNSNet Asset Value(s)
9th Aug 202311:24 amRNSHolding(s) in Company
8th Aug 20234:13 pmRNSHolding(s) in Company
1st Aug 202311:09 amRNSTotal Voting Rights
27th Jul 20234:11 pmRNSHolding(s) in Company
27th Jul 20232:36 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSAdmission, Director Dealings & Total Voting Rights
19th Jul 20237:00 amRNSCalculation of the Tender Price and Issue Price
18th Jul 20237:00 amRNSResult of Tender Offer and Issue
26th Jun 20233:55 pmRNSResult of Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.